Hepatitis C Virus Real Time PCR Kit（RUO）is intended for the quantitative in-vitro detection of the RNA of Hepatitis C virus (HCV) in serum and plasma specimens. It is mainly used to detect common HCV genotypes (1-6) in patients suspected of having HCV infection and Hepatitis C patients receiving antiviral treatment.

HCV is the causative pathogen of human hepatitis C, belonging to the genus Hepacivirus within the family Flaviviridae. The primary sources of HCV infection are blood and blood products. Persistent infection is typically asymptomatic, and approximately 80% of chronic infections may progress to cirrhosis or liver cancer. Consequently, HCV poses a significant threat to people's health. The RNA content is a direct indicator reflecting the replication and infectiousness of HCV. A high viral load in patients undergoing treatment suggests ineffectiveness, often necessitating a prolonged course of treatment. Therefore, the quantitative detection of HCV RNA in the blood is crucial. It not only reduces the risks of HCV transmission through blood transfusion but also aids in prognosis and the selection of appropriate treatment. This kit employs a quantitative fluorescence PCR technique to detect HCV RNA, offering direct evidence for diagnosing HCV infection and facilitating the evaluation of antiviral treatment effectiveness.

• LOD: 5 IU/mL
• Internal control monitors the DNA extraction and PCR amplification efficiency of specimens.
• 4 HCV Quantitative Reference Standards
• Specimen type: serum or plasma
• Small packing available: 24 tests/kit and 48 tests/kit
• Genotype coverage: The kit can be used to detect HCV genotypes 1-6

Validated PCR Instruments:

• ABI 7500 Real Time PCR System
• Bioperfectus STC-96A/96A PLUS Real Time PCR System
• Roche's LightCycler 480 PCR System